Carerx Corporation · TSX:CRRX
Carerx — Q2 2020 Earnings Presentation
14 slides from Carerx's earnings presentation, Aug 14, 2020
Slide 1: Q2 2020 Earnings Call
Slide 2: Forward Looking Statements
Forward Looking Statements Certain of the statements contained in this presentation are "forward looking information within the meaning of applicable Canadian securities legislation. Forward looking information includes, but is not limited to, business strategy, plans and other expectations, beliefs
Slide 3: David Murphy, President & Chief Executive Officer
David Murphy President & Chief Executive Officer
Slide 4: An Eventful Second Quarter
An Eventful Second Quarter + Completed acquisition of Remedy’sRx Specialty Pharmacy on May 7, 2020 * Rebranded as CareRx Corporation + Executed 20 for 1 share consolidation * Raised gross proceeds of $11.5 million through a bought deal private placement Building Better Pharmacy Services - for Senior
Slide 5: Q2 2020 Highlights
Q2 2020 Highlights Continuing Operations Revenue $39.7M +26.2% * Includes less than 2 months of contribution Average Beds Serviced 41,754 +33.6% , from the Remedy’s Adjusted EBITDA $2.8M +26.0% business Adjusted EBITDA Margin 7.1%
Slide 6: Andrew Mok, Chief Financial Officer
Andrew Mok Chief Financial Officer
Slide 7: Quarterly Results | Revenue
Quarterly Results | Revenue ($ millions) $39.7 40 | + Growth of 26.2% 35 ' 30 $31.5 | Includes less than 2 95 months of contribution 20 from Remedy’s i} 15 i Partially offset by the 10 impact of the Ontario 5 Drug Benefit Act ("ODBA’) rs) amendments i} Q2 2019 Q2 2020
Slide 8: Quarterly Results | Adjusted EBITDA
Quarterly Results | Adjusted EBITDA ($ millions) 3 $28 i * Growth of 26.0% driven mostly 25 $22 by Remedy’s acquisition 2 | + Reduced corporate costs by | 30.4% 1.5 I 1 * Impact of ODBA amendments 1 reduced Adjusted EBITDA by 0.5 $0.4 million ° Q2 2019 Q2 2020
Slide 9: Special Warrants
Special Warrants Raised gross proceeds of $11.5 million through a bought deal private placement of Special * Special Warrants converted into Warrants 2,875,000 Common Shares on August 13, * Closed on June 4, 2020 2020 * Issued 57,500,000 Special Warrants, including full exercise of underwriters’ ove
Slide 10: David Murphy, President & Chief Executive Officer
David Murphy President & Chief Executive Officer
Slide 11: Our Growing National Footprint
Our Growing National Footprint Beds serviced ~50,000 Seniors Homes >900 Monthly >1,400,000 prescriptions Geographies Western Canada & Ontario a]
Slide 12: Growth Strategy Provides Opportunity for Significant Shareholder Value
Growth Strategy Provides Opportunity for Significant Shareholder Value 12 Increase beds under contract Well capitalized and positioned to win significant new RFPs and contracts Consolidate the market Highly fragmented market provides opportunities for accretive acquisitions to increase scale and rea
Slide 13: Outlook for 2020 / 2021
Outlook for 2020 / 2021 * Integration of Remedy’s is underway * Portion of synergies to be realized this year » Expect full integration to be completed in the first half of 2021 * Growing organically * Making strategic acquisitions 13
Slide 14: Questions
J *.. Questions Visit our website at www.carerx.ca | Follow @CareRx on Twitter $$ CareRx